GPRO is up +39.02% today, trading near $1.71 during the regular session, extending a multi-day surge that has more than doubled shares off last week's ~$0.60 low. Primary driver: continued reaction to the definitive merger with private photonics firm Starman Optical, a pivot into AI data-center optics and defense that repays ~$92M of debt and pays shareholders $1.14/share plus a ~10% stake in the combined company.

BIAF is up +63.73% intraday to about $10.79, extending the prior session's +44.52% surge; the move occurred during regular market hours. Primary catalyst: the company announced plans to expand its CyPath Lung test into post-treatment surveillance of lung cancer survivors, broadening its commercial use beyond initial screening.

CRDO dropped about -18.65% in regular trading, sliding from a $206.63 prior close to roughly $168. The move extends a post-earnings selloff after fiscal Q1 results (revenue $479M, +115% YoY; EPS $1.20) beat estimates but GAAP gross margin fell to 64.5%, with Q2 guidance seen as thinner than prior quarters.

HTZ traded up +6.7% to about $2.39 during regular market hours versus the prior session's $2.24 close. The primary catalyst was a newly announced partnership with Uber to operate autonomous robotaxis and human-driven fleet operations.

Alphabet (GOOG) shares have declined roughly 10.7% over the past 30 days, slipping from a closing level near $372.47 to about $332.76 as of early September trading. The pullback reflects growing investor unease about AI capital spending, a historic turn to negative free cash flow, and the delayed rollout of the flagship Gemini 3.5 Pro model.

The $100 price target represents roughly a 139% gain from IREN's recent trading level near $42, and would require a breakout well above its prior 52-week high of $76.87. Strongest bullish factors: a landmark $9.7 billion AI cloud agreement with Microsoft and a large, largely owned power portfolio positioned for high-performance computing demand.

GTLB is up +14.62% intraday, trading near $51.68 versus a prior close of $45.09, with the move occurring during regular session trading. Primary catalyst: a strong Q2 FY2027 report, with revenue up roughly +21% year-over-year to ~$286M, beating estimates, alongside raised full-year revenue guidance.

DELL is up roughly +12.5% in Wednesday's session, trading near $478 versus Tuesday's $425.00 close, following a post-earnings surge that began after-hours and extended through premarket. The move was driven by a blowout fiscal Q2 2027 report: revenue rose +58% to about $47 billion and adjusted EPS of $7.04 crushed the ~$4.92 consensus.

PANW is down -8.48% to roughly $331.37 during regular trading, extending a post-earnings slide from Tuesday's $362.09 close. The move reflects a "beat-and-sell" reaction to Q4 FY26 results (released after Sept. 1 close), which beat revenue ($3.41B) and EPS ($1.02) but failed to satisfy lofty expectations.

FCEL dropped -10.71% to $15.25 from its prior close of $17.08, with the decline extending during regular trading. Primary catalyst: a wider-than-expected quarterly loss and a revenue miss reported before the open.

Purple Biotech (PPBT) has climbed roughly 73% over the trailing 30 days, from about $1.47 in early August to around $2.55. A U.S. patent Notice of Allowance covering tri-specific antibody designs from its CAPTN-3 platform was the primary catalyst, triggering unusually heavy trading volume.

Linkhome Holdings (LHAI) climbed roughly 44% over the last 30 days, rebounding from about $0.85 in early August to around $1.22 in early September. The advance follows a sharp late-June slide to near $0.65 and reflects renewed speculative interest in the company's pivot into AI infrastructure and GPU computing.

CRDO is down -10.45% to roughly $185 in Wednesday's session, extending an after-hours/overnight slide triggered by its fiscal Q1 report. The selloff came despite a beat: adjusted EPS of $1.20 vs. $1.17 expected and revenue up +115% YoY to $479M, above estimates.

MDB is trading down roughly -11.2% at about $385.60, versus a prior-session close of $434.21, extending an after-hours and premarket selloff into Wednesday's regular session. The move follows fiscal Q2 FY2027 results reported after Tuesday's close: revenue rose +30% to $771.8M and adjusted EPS of $1.90, both topping consensus.

The widely cited 12-month analyst price target for PPBT is $17 , implying a roughly tenfold move from recent prices in the $1.50–$2.30 range. The bullish case rests on the CAPTN-3 tri-specific antibody platform and lead candidate IM1240, which is advancing toward a first-in-human Phase 1 trial.

Linkhome Holdings Inc. ( LHAI ) trades near $0.84, far below its 52-week high of $15.66, with a market capitalization around $14 million. The $2 price target represents roughly a 140% gain from current levels — a major psychological milestone for a stock now priced as a micro-cap.

TSLA is the ticker for Tesla, Inc., an American electric vehicle (EV) and clean energy company, not an exchange-traded fund (ETF). Tesla operates two primary segments: Automotive (electric cars and trucks) and Energy Generation and Storage (solar, Powerwall, and Megapack).

Advanced packaging is a defining growth catalyst: management expects advanced-packaging process-control revenue to climb from roughly $635 million in 2025 to about $1.0–$1.1 billion in 2026, or more than 70% year-over-year growth, as AI chips demand tighter inspection and yield control. Rising process-control intensity: as leading-edge logic, DRAM (dynamic random-access memory), and high-bandwidth memory become more complex, chipmakers require more defect inspection and metrology, expanding KLA's addressable opportunity per wafer.

KLA Corporation ( KLAC ) is a leading supplier of process control and yield management equipment for the semiconductor industry. The company is headquartered in Milpitas, California, and was formed in 1997 through the merger of KLA Instruments and Tencor Instruments.

VOO is a passive, market-capitalization-weighted exchange-traded fund (ETF) that tracks the S&P 500 Index, holding approximately 500 large-cap U.S. stocks. The fund's 30-day price move is modestly positive, leaving it well inside the threshold for a range-bound rather than trend-driven market environment.